| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032961A2 Methods for preventing and treating bone loss with steroid compounds |
| 04/24/2003 | WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032907A2 High-concentration protein formulations and method of manufacture |
| 04/24/2003 | WO2003032735A1 Remodeling of tissues and organs |
| 04/24/2003 | WO2003007839A3 Devices form naturally occurring biologically derived |
| 04/24/2003 | WO2003007787A3 Cartilage repair and regeneration device and method |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002070438A3 Compositions for delivering bisphosphonates |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | WO2002050120A3 High affinity antibodies |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002038171A3 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 04/24/2003 | WO2001080856A3 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078426 Thiazolidine or oxazolidine compounds useful for preventing or therapeutical agents for various diseases such as diabetes and hyperlipemia |
| 04/24/2003 | US20030078304 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 04/24/2003 | US20030078300 Fused bicyclic or tricyclic amino acids |
| 04/24/2003 | US20030078289 Indole carboxylic acids as thyroid receptor ligands |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | US20030078212 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077271 Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disorders |
| 04/24/2003 | US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease |
| 04/24/2003 | US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | US20030077232 Oral alkyl hydroxybenzoate; antimicrobial agents |
| 04/24/2003 | US20030075172 Method and apparatus for dispensing inhalator medicament |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | CA2463925A1 Bone anti-resorptive compounds |
| 04/24/2003 | CA2463850A1 Remodeling of tissues and organs |
| 04/24/2003 | CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/24/2003 | CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 04/24/2003 | CA2463628A1 Himbacine analogues as thrombin receptor antagonists |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | CA2463142A1 Methods for preventing and treating bone loss with steroid compounds |
| 04/24/2003 | CA2463003A1 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | CA2461740A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/23/2003 | EP1304117A1 Remedies for bone diseases |
| 04/23/2003 | EP1304113A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1304112A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303610A2 Extracellular matrix protein |
| 04/23/2003 | EP1303607A2 High affinity soluble interleukin-18 receptor |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303527A1 Matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1303522A2 Biologically active macrolides, compositions, and uses thereof |
| 04/23/2003 | EP1303520A1 Therapeutic compounds and methods |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 04/23/2003 | EP1303512A1 Process for preparing arylacetylaminothiazoles |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303506A1 6-heteroarylphenanthridines |
| 04/23/2003 | EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 04/23/2003 | EP1303496A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists |
| 04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303302A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1220863B1 Purine derivatives |
| 04/23/2003 | EP1105109B1 Injectable formulations of nanoparticulate naproxen |
| 04/23/2003 | EP1100488B1 Use of creatine compounds for treatment of bone or cartilage cells and tissues |
| 04/23/2003 | EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2003 | CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same |